Ubs Group Ag Harrow Health, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Harrow Health, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 33,153 shares of HROW stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,153

Previous 26,409 25.54%

Holding current value

$1.21 Million

Previous $551,000 170.42%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$20.85 - $46.47 $140,612 - $313,393	6,744 Added 25.54%	33,153 $1.49 Million
Q2 2024 Aug 13, 2024	SELL	$10.0 - $21.64 $188,420 - $407,740	-18,842 Reduced 41.64%	26,409 $551,000
Q1 2024 May 13, 2024	SELL	$9.3 - $13.23 $576 - $820	-62 Reduced 0.14%	45,251 $598,000
Q4 2023 Feb 09, 2024	BUY	$8.1 - $16.36 $134,913 - $272,492	16,656 Added 58.12%	45,313 $507,000
Q3 2023 Nov 09, 2023	SELL	$14.03 - $22.08 $66,712 - $104,990	-4,755 Reduced 14.23%	28,657 $411,000
Q2 2023 Aug 11, 2023	BUY	$17.37 - $28.08 $319,121 - $515,885	18,372 Added 122.15%	33,412 $636,000
Q1 2023 May 12, 2023	BUY	$13.84 - $21.46 $32,136 - $49,830	2,322 Added 18.26%	15,040 $318,000
Q4 2022 Feb 08, 2023	BUY	$10.28 - $14.78 $13,148 - $18,903	1,279 Added 11.18%	12,718 $187,000
Q3 2022 Nov 10, 2022	BUY	$6.57 - $24.88 $5,492 - $20,799	836 Added 7.88%	11,439 $139,000
Q2 2022 Aug 10, 2022	SELL	$5.75 - $7.74 $20,694 - $27,856	-3,599 Reduced 25.34%	10,603 $77,000
Q1 2022 May 16, 2022	SELL	$6.77 - $8.66 $5,612 - $7,179	-829 Reduced 5.52%	14,202 $97,000
Q4 2021 Feb 14, 2022	SELL	$8.5 - $12.0 $25,738 - $36,336	-3,028 Reduced 16.77%	15,031 $130,000
Q3 2021 Nov 15, 2021	BUY	$6.99 - $10.6 $1,230 - $1,865	176 Added 0.98%	18,059 $164,000
Q2 2021 Aug 13, 2021	SELL	$6.68 - $11.07 $31,355 - $51,962	-4,694 Reduced 20.79%	17,883 $166,000
Q1 2021 May 12, 2021	SELL	$6.26 - $11.03 $129,394 - $227,990	-20,670 Reduced 47.8%	22,577 $152,000
Q4 2020 Feb 11, 2021	BUY	$4.76 - $6.93 $59,904 - $87,214	12,585 Added 41.04%	43,247 $297,000
Q3 2020 Nov 12, 2020	SELL	$4.71 - $7.36 $40,119 - $62,692	-8,518 Reduced 21.74%	30,662 $171,000
Q2 2020 Jul 31, 2020	BUY	$3.61 - $6.47 $55,673 - $99,780	15,422 Added 64.91%	39,180 $204,000
Q1 2020 May 01, 2020	SELL	$3.5 - $7.31 $15,963 - $33,340	-4,561 Reduced 16.11%	23,758 $90,000
Q4 2019 Feb 14, 2020	BUY	$4.6 - $7.88 $12,976 - $22,229	2,821 Added 11.06%	28,319 $220,000
Q3 2019 Nov 14, 2019	SELL	$4.89 - $8.0 $21,794 - $35,656	-4,457 Reduced 14.88%	25,498 $144,000
Q2 2019 Aug 14, 2019	BUY	$4.2 - $8.7 $3,339 - $6,916	795 Added 2.73%	29,955 $261,000
Q1 2019 May 14, 2019	BUY	$4.75 - $7.1 $138,510 - $207,036	29,160 New	29,160 $145,000

Others Institutions Holding HROW

# of Institutions

177

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account